Contribution of the N-terminal and C-terminal domains of haemaphysalin to inhibition of activation of plasma kallikrein-kinin system.

Haemaphysalin is a kallikrein-kinin system inhibitor from hard tick Haemaphysalis longicornis, and consists of two Kunitz type protease inhibitor domains. Each domain as well as haemaphysalin inhibited intrinsic coagulation by inhibiting activation of the kallikrein-kinin system without affecting the amidolytic activities of intrinsic coagulation factors, indicating that both domains were involved in the inhibition through a similar mechanism to that for haemaphysalin. Reconstitution experiments showed that the C-terminal domain contributed more predominantly to this inhibition. Direct binding assaying showed that the C-terminal domain could bind to the cell-binding region of high molecular weight kininogen (HK), suggesting that it also binds to the cell-binding region of factor XII. Judging from these findings, the C-terminal domain may more effectively inhibit the association of factor XII and HK with the cell surface by binding to cell-binding regions, and hence would predominantly contribute to the inhibition of activation of the kallikrein-kinin system.

[1]  M. Dennis,et al.  Ecotin is a potent inhibitor of the contact system proteases factor XIIa and plasma kallikrein , 1995, FEBS letters.

[2]  A. James,et al.  Anticoagulants in vector arthropods. , 1996, Parasitology today.

[3]  A. Schmaier,et al.  Identification of prolylcarboxypeptidase as the cell matrix‐associated prekallikrein activator , 2002, FEBS letters.

[4]  J. Andersen,et al.  Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex. , 2002, Blood.

[5]  F. Citarella,et al.  Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage , 1997, British journal of haematology.

[6]  J. Ribeiro,et al.  Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis , 2004, Thrombosis and Haemostasis.

[7]  A. Schmaier,et al.  Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. , 2002, Blood.

[8]  A. Schmaier,et al.  High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. , 1998, Blood.

[9]  T. Halkier,et al.  Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen. , 1991, European journal of biochemistry.

[10]  P. Keller,et al.  Cloning of the cDNA and expression of moubatin, an inhibitor of platelet aggregation. , 1993, The Journal of biological chemistry.

[11]  J. Sun,et al.  Expression, reconstitution and characterization of prolixin-S as a vasodilator--a salivary gland nitric-oxide-binding hemoprotein of Rhodnius prolixus. , 1997, European journal of biochemistry.

[12]  J. Ribeiro Role of saliva in blood-feeding by arthropods. , 1987, Annual review of entomology.

[13]  R. Colman,et al.  Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. , 1992, The Journal of biological chemistry.

[14]  I. Schousboe,et al.  The surface-dependent autoactivation mechanism of factor XII. , 1997, European journal of biochemistry.

[15]  J. Ribeiro,et al.  Exploring the sialome of the tick Ixodes scapularis. , 2002, The Journal of experimental biology.

[16]  T. Connolly,et al.  Isolation of an inhibitor selective for collagen-stimulated platelet aggregation from the soft tick Ornithodoros moubata. , 1993, The Journal of biological chemistry.

[17]  S. Reddigari,et al.  Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. , 1993, The Journal of biological chemistry.

[18]  H. Herwald,et al.  Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation. , 2001, European journal of biochemistry.

[19]  M. Lerner,et al.  Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. , 1991, The Journal of biological chemistry.

[20]  J. H. Law,et al.  Biochemical insights derived from insect diversity. , 1992, Annual review of biochemistry.

[21]  J. Sun,et al.  Purification, Characterization and cDNA Cloning of a Novel Anticoagulant of the Intrinsic Pathway, (Prolixin-S), from Salivary Glands of the Blood Sucking Bug, Rhodnius prolixus , 1996, Thrombosis and Haemostasis.

[22]  A. James,et al.  The transcriptome of adult female Anopheles darlingi salivary glands , 2004, Insect molecular biology.

[23]  A. Schmaier,et al.  Recombinant prolylcarboxypeptidase activates plasma prekallikrein. , 2004, Blood.

[24]  H. Isawa,et al.  Identification and characterization of the plasma kallikrein-kinin system inhibitor, haemaphysalin, from hard tick, Haemaphysalis longicornis , 2005, Thrombosis and Haemostasis.

[25]  D. E. Smith,et al.  Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. , 1990, Science.

[26]  R. Huber,et al.  The ornithodorin‐thrombin crystal structure, a key to the TAP enigma? , 1996, The EMBO journal.

[27]  R. Colman,et al.  Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. , 2000, Blood.

[28]  P. D. de Groot,et al.  The binding of high molecular weight kininogen to cultured human endothelial cells. , 1988, The Journal of biological chemistry.

[29]  J. Andersen,et al.  Exploring the sialome of the blood-sucking bug Rhodnius prolixus. , 2004, Insect biochemistry and molecular biology.

[30]  A. Schmaier,et al.  Identification and Characterization of Prolylcarboxypeptidase as an Endothelial Cell Prekallikrein Activator* , 2002, The Journal of Biological Chemistry.

[31]  H. Saito Contact Factors in Health and Disease , 1987, Seminars in thrombosis and hemostasis.

[32]  S. Olson,et al.  Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement. , 1993, The Journal of biological chemistry.

[33]  S. Iwanaga,et al.  Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein. , 1987, Journal of Biochemistry (Tokyo).

[34]  H. Halvorson,et al.  Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies. , 1993, The Journal of biological chemistry.

[35]  A. Schmaier,et al.  Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5 (*) , 1995, The Journal of Biological Chemistry.

[36]  M. Helmer-Citterich,et al.  Identification of a Putative Binding Site for Negatively Charged Surfaces in the Fibronectin Type II Domain of Human Factor XII , 2000, Thrombosis and Haemostasis.

[37]  A. Schmaier,et al.  Activation of the plasma kallikrein/kinin system on endothelial cell membranes. , 1999, Immunopharmacology.